Opinion: The Potential of Neurofilament Light Chain as a Biomarker in Parkinson’s Disease

While sensitive and specific biomarkers for Alzheimer’s disease have recently taken a leap forward, the Parkinson’s space has lagged behind. Neurofilament Light Chain could change that.